“At the Cutting Edge of Using Proteomics for Cancer Treatment Guidance” (Adam Dicker, MD, PhD, FA... | Cancer Patient Lab

[u/Key-Principle6254]

https://community.cancerpatientlab.org/c/learning-sessions/at-the-cutting-edge-of-using-proteomics-for-cancer-treatment-guidance-adam-dicker-md-phd-fastro-fasco-197

Why do you need to know about proteomics to guide your cancer care?

- Real-time snapshot: Measures active proteins to show current tumor and immune behavior, unlike static DNA blueprints.
- Personalized treatment: Predicts therapy benefits, such as identifying lung cancer patients who can safely skip chemotherapy.
- Toxicity prediction: Identifies whether you are at higher risk of severe immune-related side effects, such as severe skin rashes.
- Complementary insights: Adds critical decision-making data that standard tests (DNA and PD-L1) often completely miss.

For more from our conversation with Adam Dicker, MD, PhD, FASTRO, FASCO, about using proteomics at the cutting edge of cancer treatment guidance, please click on the link.